Ceftazidime
Ceftazidime for Injection, USP
Approved
Approval ID
aec64360-8452-4987-a366-a5a4f8762ab6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 3, 2024
Manufacturers
FDA
Sagent Pharmaceuticals
DUNS: 080579617
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ceftazidime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25021-129
Application NumberANDA062640
Product Classification
M
Marketing Category
C73584
G
Generic Name
ceftazidime
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 3, 2024
FDA Product Classification
INGREDIENTS (2)
sodium carbonateInactive
Code: 45P3261C7T
Classification: IACT
ceftazidimeActive
Quantity: 6 g in 30 mL
Code: 9M416Z9QNR
Classification: ACTIM